Halozyme Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

15.07.22	Pre-market Movers: USEA, GRRR, SSU, ELA, LPG… (RTTNews)
12.07.22	Pre-market Movers: AWX, GOEV, CSSE, OB, KSPN… (RTTNews)
23.06.22	Concerned Shareholders of Akanda Corp. Replace a Majority of Akanda's Board of Directors (PR Newswire)
10.05.22	Ausblick: Halozyme Therapeutics vermeldet Zahlen zum jüngsten Quartal (finanzen.net)
13.04.22	Halozyme Therapeutics To Buy Antares For $5.60/shr; Reaffirms FY22 View (RTTNews)
22.03.22	Halozyme: ENHANZE Drug Delivery Technology Part Of Argenx's Positive Trial Of SC Efgartigimod In GMG (RTTNews)
21.02.22	Ausblick: Halozyme Therapeutics mit Zahlen zum abgelaufenen Quartal (finanzen.net)
10.01.22	Halozyme Therapeutics Issues 2022 Guidance; Projects Revenue Growth Of 23-26% (RTTNews)
19.08.21	FlowerShop* Launches BUDVASE, Premium Line of Mood-and-Sensory Based Cannabis, Aromatherapy, Home Goods, and Lifestyle Products (PR Newswire)
16.08.21	Halo Collective Reports Second Quarter 2021 Financial Results (PR Newswire)
11.08.21	Halo Collective Announces Date for Second Quarter 2021 Financial Results and Earnings Call (PR Newswire)
09.08.21	Halozyme Therapeutics, Inc. Q2 adjusted earnings Beat Estimates (RTTNews)
09.08.21	Halozyme Reports Second Quarter 2021 Results (PR Newswire)
07.08.21	Ausblick: Halozyme Therapeutics präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net)
03.08.21	/R E P E A T -- Akanda Corp. Engages Boustead Securities as Exclusive Financial Advisor/ (PR Newswire)
03.08.21	/R E P E A T -- Halo Collective Announces Changes to Board of Directors as Additional Steps Toward Creation of Akanda/ (PR Newswire)
30.07.21	Akanda Corp. Engages Boustead Securities as Exclusive Financial Advisor (PR Newswire)
30.07.21	Halo Collective Announces Changes to Board of Directors as Additional Steps Toward Creation of Akanda (PR Newswire)
30.07.21	Halozyme to Participate in Canaccord Genuity 41st Annual Growth Conference (PR Newswire)
27.07.21	Halozyme To Host Second Quarter 2021 Financial Results Webcast and Conference Call (PR Newswire)
26.07.21	/C O R R E C T I O N from Source -- Halo Collective Inc./ (PR Newswire)
24.07.21	Halo Collective Plans to Acquire William's Wonder Farms (PR Newswire)
21.07.21	Halo Collective Awarded Large White Label Contract by Papa's Herb®, a Leading California Brand (PR Newswire)
20.07.21	Halo Collective Completes Securities Issuance to Independent Consultants, Related Parties, and Suppliers (PR Newswire)
19.07.21	Papa's Herb® Enters the Oregon Market Through Halo Collective (PR Newswire)
15.07.21	/R E P E A T -- Halo Collective Announces Purchase of KushBar Retail Assets from High Tide/ (PR Newswire)
15.07.21	High Tide and Halo Announce Closing of Sale of KushBar Assets to Halo (PR Newswire)
15.07.21	High Tide and Halo Announce Closing of Sale of KushBar Assets to Halo (PR Newswire)
15.07.21	Halo Collective Announces Purchase of KushBar Retail Assets from High Tide (PR Newswire)
12.07.21	Halozyme Announces Janssen Receives U.S. FDA Approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma... (PR Newswire)
25.06.21	Halo Collective Announces Corporate Update Conference Call Today June 25th (PR Newswire)
23.06.21	Halo Collective Announces Results of Annual General and Special Meeting (PR Newswire)
22.06.21	Halozyme Announces Janssen Receives European Marketing Authorizations for DARZALEX® (daratumumab) Subcutaneous Formulation for Newly Diagnosed Systemic Light-chain Amyloidosis and Pre-Treated Mult... (PR Newswire)
22.06.21	/R E P E A T -- Halo Collective Announces Reorganization of International Assets to Create Akanda, a Leading African Medical Cannabis Company/ (PR Newswire)
22.06.21	Halo Collective Announces Reorganization of International Assets to Create Akanda, a Leading African Medical Cannabis Company (PR Newswire)
22.06.21	ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE® drug delivery technology to enable development of "ultra-long-acting" medicines for HIV (PR Newswire)
22.06.21	Halo Collective Completes Transaction with Elegance Brands (PR Newswire)
07.06.21	Elegance Brands Enters Strategic Partnership and Licensing Arrangement with Halo Collective to Launch THC Beverage Portfolio (PR Newswire)
01.06.21	Die Expertenmeinungen zur Halozyme Therapeutics-Aktie im Mai 2021 (finanzen.net)
21.05.21	Janssen Gets Two Positive CHMP Opinions For Darzalex Subcutaneous Formulation Utilizing Enhanze (RTTNews)
08.05.21	Ausblick: Halozyme Therapeutics gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net)
25.04.21	Erste Schätzungen: Halozyme Therapeutics präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net)
21.02.21	Ausblick: Halozyme Therapeutics vermeldet Zahlen zum jüngsten Quartal (finanzen.net)
08.02.21	Erste Schätzungen: Halozyme Therapeutics gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net)
28.12.20	Biotech Stock Picks That Delivered Triple-digit Gains - Is There More Room To Run? (RTTNews)
01.11.20	Ausblick: Halozyme Therapeutics öffnet die Bücher zum abgelaufenen Quartal (finanzen.net)
09.08.20	Ausblick: Halozyme Therapeutics zieht Bilanz zum jüngsten Jahresviertel (finanzen.net)
31.07.20	So stuften die Analysten die Halozyme Therapeutics-Aktie im vergangenen Monat ein (finanzen.net)
31.05.20	Mai 2020: So haben Analysten ihre Einstufung der Halozyme Therapeutics-Aktie angepasst (finanzen.net)
10.05.20	Ausblick: Halozyme Therapeutics gewährt Anlegern Blick in die Bücher (finanzen.net)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.14	1.54 %	K V
UBS Group	28.08	1.48 %	K V
Swiss Re	130.05	1.05 %	K V
Part Grp Hldg	1’266.00	0.96 %	K V
ABB	49.48	0.94 %	K V
Geberit	525.20	0.27 %	K V
Alcon	78.04	0.05 %	K V
Givaudan	3’868.00	-0.31 %	K V
CieFinRichemont	121.20	-0.57 %	K V
Sonova Hldg	301.00	-0.99 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Halozyme Therapeutics Inc.

Aktien Top/Flop

Meistgelesene Nachrichten